Before a prescription, make the purpose clear.
The conversation can lead to a prescription, more assessment or a different plan. Start with room for all three.
What are we trying to help with?
Name the condition and the goal before getting into the medicine.
Bring this up What are we trying to change, and how would we know the plan was helping?
The approved uses have limits. Weight management and sleep apnea are different questions, and a liver or heart-failure study doesn’t add an approved use. Putting the purpose into ordinary words helps keep the discussion focused.
Promise Peptides is a U.S. telehealth service whose licensed providers assess requests for compounded Tirzepatide. The provider decides whether to prescribe, and some people don’t qualify. Compounded medicines are not FDA-approved.
Which medicine is being considered?
Ask for the product name as well as the ingredient.
Bring this up Why this version, and what patient need and legal basis support it if it is compounded?
FDA approval belongs to named products, including Mounjaro (tirzepatide) and Zepbound (tirzepatide). Compounded preparations are not FDA-approved. FDA explains that it does not check their safety, effectiveness or quality before marketing. The same ingredient name doesn’t give every version the same status.
There are legal limits on compounding, too. FDA’s shortage-policy history records the tirzepatide shortage resolution and the end of shortage-related grace periods. That history is not blanket permission to make copies. A proposed compounded medicine needs a lawful basis and a reason specific to the patient.
What could change the answer?
Your history, other medicines and upcoming plans belong in the conversation.
Bring this up What does the prescriber need to know about my health, medicines and planned procedures?
The labels rule out use with a personal or family history of medullary thyroid carcinoma, a rare thyroid cancer, or MEN 2, a rare inherited condition. Previous serious allergy matters too. Pancreas, gallbladder or severe stomach-emptying problems can also affect the discussion.
Pregnancy plans, birth control pills, diabetic eye disease and procedures with anesthesia all need attention. So do insulin and certain other diabetes medicines. Our side-effects page explains the cautions. A complete medicine list is more helpful than trying to guess which item counts.
Who helps after the decision?
Make the follow-up route as clear as the first appointment.
Bring this up Whom do I contact, and when will we review how things are going?
For online care, licensure depends on the patient’s location. The clinician needs the appropriate license or legal permission for where you are during the appointment. A website’s national reach doesn’t settle that.
There are practical questions too: who reviews progress, who checks unclear instructions and how urgent concerns are handled. The dosage page explains study numbers, but it can’t set your schedule. A written amount is one part of an ongoing care plan.